Prednisone Effects and Side Effects
Direct Answer
Prednisone causes dose-dependent and duration-dependent side effects affecting nearly every organ system, with the most serious complications—including osteoporosis, infections, metabolic disturbances, and neuropsychiatric effects—occurring primarily at doses >10 mg daily for prolonged periods. 1
Therapeutic Effects
Prednisone provides potent anti-inflammatory and immunosuppressive effects that are beneficial for treating various inflammatory and autoimmune conditions. 2 The clinical benefits typically outweigh risks when used appropriately at the lowest effective dose for the shortest duration. 1, 2
Short-Term Side Effects (First Few Weeks to 6 Weeks)
Common Early Effects
- Weight gain and fluid retention occur within the first few weeks and are among the most frequently reported patient concerns 1, 3
- Increased appetite leading to additional weight gain 1, 3
- Insomnia, restlessness, and nervousness affect over 30% of patients 1, 3
- Facial rounding (moon face) can begin developing even during short-term use 1, 3
- Mood disturbances ranging from euphoria and hypomania to depression, anxiety, and emotional instability 1, 3
- Gastric irritation and increased risk of peptic ulcer formation 3, 4
- Hypertension can develop or worsen quickly 3, 4
Critical Threshold
Duration of treatment longer than 6 weeks significantly increases the risk of adverse effects. 3 Most short-term side effects are dose-dependent, with higher doses causing more frequent and severe reactions. 3
Long-Term Side Effects (>6 Weeks, Especially >10 mg Daily)
Musculoskeletal Complications (Most Serious)
- Osteoporosis and increased fracture risk are among the most serious complications, with vertebral compression fractures occurring in up to 27% of patients 1, 3
- Aseptic necrosis of femoral and humeral heads can develop even at moderate doses 1, 3
- Myopathy affecting diaphragmatic and intercostal muscles 3, 4
- Even doses as low as 5 mg daily can suppress bone formation markers in postmenopausal women 5
Metabolic and Endocrine Effects
- Hyperglycemia and worsening of diabetes are common, particularly with prednisone, requiring blood glucose monitoring 1, 3
- Redistribution of body fat with truncal obesity, moon facies, and buffalo hump occurs in 80% of patients after two years 1, 3
- HPA axis suppression with potential for adrenocortical insufficiency that may persist up to 12 months after discontinuation 4
- Dyslipidemia increasing cardiovascular disease risk 3
Ophthalmologic Effects
- Posterior subcapsular cataracts develop with prolonged use 1, 3, 4
- Increased intraocular pressure and glaucoma can occur 1, 3, 4
- Regular eye examinations are essential for long-term users 1, 3
Neuropsychiatric Effects
- Severe mood disturbances including depression, psychosis, delirium, and cognitive impairment 1, 4
- Memory deficits, impaired concentration, and personality changes 4
- Psychiatric symptoms occur in over 30% of patients, with severe effects mainly at doses >20 mg/day 1, 6
Dermatologic Effects
- Skin atrophy, thinning, and fragility 1, 3, 4
- Impaired wound healing 4
- Ecchymoses, petechiae, and striae 4
Infectious Complications
- Increased risk of both opportunistic and non-opportunistic infections, including pneumonia, skin infections, and sepsis 1, 3, 4
- Reactivation of latent tuberculosis 4
- Hepatitis B virus reactivation in carriers 4
- Varicella and measles can have serious or fatal courses in non-immune patients 4
- Exacerbation of systemic fungal infections 4
- Activation of latent amebiasis and Strongyloides 4
- Infections can be masked by corticosteroid effects 4
Cardiovascular Effects
- Hypertension or aggravation of existing hypertension 1, 4
- Salt and water retention with increased potassium excretion 4
- Left ventricular free wall rupture after recent myocardial infarction (use with great caution) 4
- Thromboembolism and thrombophlebitis 4
Gastrointestinal Effects
- Peptic ulcer with possible perforation and hemorrhage 1, 4
- Perforation of small and large intestine, particularly in inflammatory bowel disease 4
- Pancreatitis 4
Dose-Dependent Risk Profile
Critical Dose Thresholds
- Doses >20 mg/day for >18 months: Severe adverse effects occur in approximately 15% of patients 1, 3, 6
- Doses >10 mg daily for prolonged periods: Significantly increase risk of serious complications 1, 3
- Doses 5-10 mg daily: Still associated with increased adverse events (OR 4.5) compared to no prednisone 7
- Doses >10-15 mg daily: Most strongly correlated with adverse events (OR 32.3) 7
Even low doses (5 mg daily) can suppress bone formation and may have adverse effects on bone mass. 5
Critical Monitoring Requirements
Baseline Screening
- Screen for hepatitis B infection before initiating immunosuppressive treatment 4
- Rule out latent tuberculosis or provide chemoprophylaxis during prolonged therapy 4
- Rule out latent amebiasis in patients who have spent time in the tropics 4
Ongoing Monitoring
- Blood pressure and blood glucose monitoring regularly 1, 3
- Bone density testing (baseline and annual) for long-term therapy 1, 3
- Regular eye examinations for cataracts and glaucoma 1, 3
- Monitor for signs of infection and consider dose reduction if infections develop 4
- Psychiatric evaluation between 2-4 weeks for mood instability, sleep disturbances, agitation, and psychotic symptoms 6
Prevention Strategies
Mandatory Prophylaxis
- Calcium and vitamin D supplementation for all patients receiving corticosteroids to prevent osteoporosis 1, 3
- Pneumocystis jirovecii pneumonia prophylaxis for patients taking ≥20 mg prednisone for ≥4 weeks 1, 3
Exposure Prophylaxis
- Varicella zoster immune globulin if exposed to varicella; consider antiviral agents if varicella develops 4
- Immunoglobulin if exposed to measles 4
- Update all vaccines before starting immunosuppressive therapy; avoid live vaccines once on treatment 3
Dose Minimization Strategies
- Use the lowest effective dose for the shortest duration possible 3
- Consider alternate-day therapy when appropriate to reduce adrenal suppression 3
- Consider steroid-sparing agents when long-term therapy is anticipated 3
- In non-cirrhotic patients with specific conditions, consider budesonide instead of systemic prednisolone (significantly fewer psychiatric side effects) 6
Special Population Considerations
Pediatric Patients
- Growth suppression is a major concern, occurring even at low systemic doses without laboratory evidence of HPA axis suppression 1, 3
- Higher risk for HPA axis suppression with topical steroids due to higher skin surface/body mass ratio 3
Elderly Patients
High-Risk Patients
- Patients with diabetes, chronic liver disease, or chronic kidney disease have increased risk of complications and require close monitoring 3
- Patients with bipolar disorder or history of steroid-induced psychosis should avoid prednisone/prednisolone entirely if possible 6
Pregnancy Considerations
- Low-dose corticosteroids (≤10 mg daily) have not been proven to cause fetal wastage, prematurity, or congenital malformations 8
Common Pitfalls to Avoid
Withdrawal Management
- Never abruptly discontinue prednisone after prolonged use; adrenocortical insufficiency may result from too rapid withdrawal 4
- HPA axis suppression may persist up to 12 months after discontinuation; reinstitute hormone therapy during stress situations 4
- Gradual dose reduction minimizes withdrawal complications 4
Infection Management
- Do not underestimate infection risk; corticosteroid-associated infections can be mild but can be severe and at times fatal 4
- Signs of infection may be masked by corticosteroid effects 4
- Consider prednisone withdrawal or dosage reduction when infections develop 4
Quality of Life Impact
- Do not underestimate the impact of sleep disturbances and mood changes on quality of life 3
- Insomnia was the chief side effect in short-term treatment in clinical studies 2
Thyroid Considerations
- Metabolic clearance of corticosteroids is decreased in hypothyroid patients and increased in hyperthyroid patients; adjust dosage accordingly 4
Stress Dosing
- Increased dosage is indicated in patients on corticosteroid therapy subjected to unusual stress before, during, and after the stressful situation 4